BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37061075)

  • 1. The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives.
    Carconi C; Cerreti M; Roberto M; Arrivi G; D'Ambrosio G; De Felice F; Di Civita MA; Iafrate F; Lucatelli P; Magliocca FM; Picchetto A; Picone V; Catalano C; Cortesi E; Tombolini V; Mazzuca F; Tomao S
    Crit Rev Oncol Hematol; 2023 Jun; 186():103990. PubMed ID: 37061075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligometastatic Colorectal Cancer: A Review of Definitions and Patient Selection for Local Therapies.
    Miller ED; Hitchcock KE; Romesser PB
    J Gastrointest Cancer; 2023 Dec; 54(4):1116-1127. PubMed ID: 36652155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multidisciplinary management of oligometastases from colorectal cancer: a narrative review.
    Chandy ETJ; Saxby HJ; Pang JW; Sharma RA
    Ann Palliat Med; 2021 May; 10(5):5988-6001. PubMed ID: 32921074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Local ablative radiotherapy of oligometastatic colorectal cancer].
    Petersen C; Gauer T
    Radiologe; 2017 Feb; 57(2):105-110. PubMed ID: 28054139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiation therapy in the treatment of cancer patients with oligometastatic disease: a real world study.
    Stefanovic M; Calvet G; Pérez-Montero H; Esteve A; Bujalance MV; Navarro-Martín A; Fernández MDA; González FF; Borras SM; Borbalas AL; Fernandez MN; Garau MM; Calduch AL; Edo FG
    Clin Transl Oncol; 2023 Jan; 25(1):199-206. PubMed ID: 36068449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligometastatic breast cancer: where are we now and where are we headed?-a narrative review.
    Kent CL; McDuff SGR; Salama JK
    Ann Palliat Med; 2021 May; 10(5):5954-5968. PubMed ID: 32921069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapy.
    Franzese C; Comito T; Toska E; Tozzi A; Clerici E; De Rose F; Franceschini D; Navarria P; Reggiori G; Tomatis S; Scorsetti M
    Radiother Oncol; 2019 Apr; 133():220-226. PubMed ID: 30414754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part II: prostate cancer and colorectal cancer.
    Conde-Moreno AJ; González-Del-Alba A; López-Campos F; López López C; Requejo OH; de Castro Carpeño J; Chicas-Sett R; de Paz Arias L; Montero-Luis Á; Pérez AR; Font EF; Arija JÁA
    Clin Transl Oncol; 2023 Apr; 25(4):897-911. PubMed ID: 36525230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local ablative stereotactic body radiotherapy for oligometastatic prostate cancer.
    Niazi T; Elakshar S; Stroian G
    Curr Opin Support Palliat Care; 2018 Sep; 12(3):351-358. PubMed ID: 29979320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of a large multi-institutional database reveals important associations between treatment parameters and clinical outcomes for stereotactic body radiotherapy (SBRT) of oligometastatic colorectal cancer.
    Sheikh S; Chen H; Sahgal A; Poon I; Erler D; Badellino S; Dagan R; Foote MC; Louie AV; Redmond KJ; Ricardi U; Biswas T
    Radiother Oncol; 2022 Feb; 167():187-194. PubMed ID: 34952002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extending the Frontiers Beyond Thermal Ablation by Radiofrequency Ablation: SBRT, Brachytherapy, SIRT (Radioembolization).
    Hass P; Mohnike K
    Viszeralmedizin; 2014 Aug; 30(4):245-52. PubMed ID: 26288597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
    Eggert T; Greten TF
    Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy.
    Nicosia L; Cuccia F; Mazzola R; Ricchetti F; Figlia V; Giaj-Levra N; Rigo M; Tomasini D; Pasinetti N; Corradini S; Ruggieri R; Alongi F
    Strahlenther Onkol; 2020 Sep; 196(9):813-820. PubMed ID: 32399637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of image-guided therapy in the management of colorectal cancer metastatic disease.
    de Baere T; Tselikas L; Yevich S; Boige V; Deschamps F; Ducreux M; Goere D; Nguyen F; Malka D
    Eur J Cancer; 2017 Apr; 75():231-242. PubMed ID: 28237869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
    Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
    Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiation therapy for metastatic lung metastases.
    Kimura T; Fujiwara T; Kameoka T; Adachi Y; Kariya S
    Jpn J Radiol; 2022 Oct; 40(10):995-1005. PubMed ID: 36097233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience.
    Vernaleone M; Bonomo P; Di Cataldo V; Saieva C; Masi L; Desideri I; Greto D; Francolini G; Becherini C; Livi L
    Radiol Med; 2019 Sep; 124(9):870-876. PubMed ID: 31104277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curative-intent radiotherapy in patients with oligometastatic lesions from colorectal cancer: A single-center study.
    He X; Zhang P; Li Z; Bi F; Xu F; Wang X; Shen Y; Li Q; Qiu M
    Medicine (Baltimore); 2018 Oct; 97(40):e12601. PubMed ID: 30290630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: Systematic review.
    Kobiela J; Spychalski P; Marvaso G; Ciardo D; Dell'Acqua V; Kraja F; Błażyńska-Spychalska A; Łachiński AJ; Surgo A; Glynne-Jones R; Jereczek-Fossa BA
    Crit Rev Oncol Hematol; 2018 Sep; 129():91-101. PubMed ID: 30097241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Contemporary Update on the Role of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases in the Evolving Landscape of Oligometastatic Disease Management.
    Robin TP; Raben D; Schefter TE
    Semin Radiat Oncol; 2018 Oct; 28(4):288-294. PubMed ID: 30309639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.